Final Program in it's entirety - MyGirlsBlood

Recommendations

Info

Posters, Sunday and Monday Index of Poster Presenters cont’d 06P30 A Case of a 3-Year-Old Boy with Severe Hemophilia A on Prophylaxis Identified with Chronic Subdural Hematoma Two Years after the First Episode of Acute Subdural Hematoma Matsumoto T, Sakata K, Wada H, Kumamoto T, Katayama N, Komada Y Mie University Hospital, Division of Blood Transfusion, Tsu City, Japan 06P31 Pharmacologic Venous Thromboembolism Prophylaxis in Hemophilic Patients under Major Orthopaedic Surgery: Experience and Safety Profile Mingot M 1 , Prieto-Bonilla M 1 , Palomo-Bravo A 1 , Heiniger A 1 , Villanueva F 2 1 Hematology Oncology Department, and 2 Orthopedic Department, Regional University, Hospital Carlos Haya, Málaga, Spain 06P32 Arthrocentesis in Acute Hemarthrosis in Hemophilia without Inhibitor Pérez R 1 , Nuñez R 1 , Povedano J 2 1 Hemophilia Unit, and 2 Deparment of Rheumatology, Hospital Virgen del Rocío, Sevilla, Spain 06P33 A High-Dose Model of Hemophilia A Prophylactic Treatment Plyushch O, Kopylov K, Kumskova M, Kudryavtseva L, Zozulya N National Research Hematology Center, Moscow, Russia 06P34 Conditions of Birth of Severe Hemophilia Patients in Paris Area: A Series of 86 Patients Peynet J 2 , Rafowicz A 1 , Lambert T 3 , d’Oiron R 4 1 CRTH du CHU du Kremlin-Bicêtre, 2 CTH du CH André Mignot de Versailles, 3 CRTH du CHU du Kremlin-Bicêtre, 4 CRTH du CHU du Kremlin-Bicêtre, France 06P35 Experiences of Activated Prothrombin Complex Concentrate for Prophylaxis in Three Hemophilia Patients with Inhibitors Salcioglu Z, Akcay A, Sayilan Sen H, Aydogan G, Akici F, Tugcu D Clinics of Pediatric Hematology-Oncology, Ministry of Health, Istanbul, Turkey 06P36 A More Effective Treatment Algorithm for Hemophilia Patients in Countries with Less Access to Factor Concentrates Seuser A 1 , Navarrete Duran M 2 , Auerswald G 3 , Wendel M 4 , Chaverri P 5 1 Kaiser-Karl-Klinik Bonn, Germany, 2 Childrens Hospital San José, Costa Rica, 3 Prof.-Hess Childrens Hospital Bremen, Germany, 4 Institut für Bewegungsanalyse Bonn, Germany, 5 Hospital Mexico San José, Costa Rica 48 06P37 Surgery for Malignant Neoplasms in Hemophilia Patients Szczepanik A, Windyga J, Misiak A, Stefanska-Windyga E, Meissner A Institute of Hematology and Transfusion Medicine, Warsaw, Poland 06P38 Type of F8 Gene Mutation in Patients with Hemophilia A Undergoing Prosthetic Surgery Tagariello G, Sartori R, Tassinari C, Belvini D, Salviato R, Radossi P Haemophilia Center Transfusion and Haematology, Castelfranco Veneto Haemophilia Centre, Italy 06P39 Association between Hemophilia and Inherited Throm - bophilia: A Single Center Survey Tagliaferri A 1 , Di Perna C 1 , Riccardi F 1 , Rivolta G 1 , Pattacini C 1 , Franchini M 2 1 Regional Reference Centre for Inherited Bleeding Disorders and 2 Immunohematology and Transfusion Centre, University Hospital of Parma, Parma, Italy 06P40 Inter-Observer Reliability of Three Different Radiographic Evaluation Systems for Hemophilic Arthropathy Takedani H 1 , Fujii T2 , Kobayasi Y3 , Haga N4 Tatsunami S5 1Research Hospital of The Institute of Medical Science, The University of Tokyo, 2Hiroshima University Hospital, 3Fukuoka Houeikai Hospital, 4The University of Tokyo, 5St. Marianna University School of Medicine, Japan 06P41 Relationship between Hemarthrosis and Hemophilic Arthropathy Takedani H 1 , Fujii T 2 , Miura A 3 , Amano K 4 , Matumoto T 5 , Higasa S 6 1 Research Hospital of the Institute of Medical Science, University of Tokyo, 2 Hiroshima University Hospital, 3 Nishitaga National Hospital, 4 Tokyo Medical University Hospital, 5 Mie University Hospital, 6 Hyogo College of Medicine, Japan 06P42 ADAMTS13 Levels may Influence the Clinical Expression of Severe Hemophilia A Teitel J 1 , Walker I 2 , Harrington A 1 , Almonte T 2 , Jiang D 1 , Lau H 1 1 University of Toronto, 2 McMaster University, ON, Canada 06P43 A New Bleeding Score for a Quantitative Assessment of Bleeding in Hemorrhagic Disorders Delahaye M, Trossaert M, Billon M, Lefrancios A, Sigaud M, Fouassier M Haemophilia Center, University Hospital, Nantes, France
Index of Poster Presenters cont’d 06P44 Morphine Consumption Post-Arthroplasty in Patients with Severe Hemophilia: Is the Peripheral Nerve Block Still Contraindicated? Desdoits A1 , Trossaërt M2 , Lejus C1 1Anaesthesiology-Reanimation, University Hospital Hôtel- Dieu and Hôpital Mère-Enfant., Nantes, France, 2Hemophilia Center, University Hospital, Nantes, France 06P45 Assessment of Response to Intra Articular Rifampicin into 14 Target Knee Joints in Adolescents Vidyatilake H1 , Yogananda P2 1 2 Lady Ridgeway Children’s Hospital, Faculty of Medicine, University of Colombo, Sri Lanka 06P46 A Multi-Centre, Multi-National, Open-Label Sequential Trial Comparing Pharmacokinetics and Safety of a New Recombinant FVIII Compound (N8) and Advate ® in Patients with Hemophilia A Martinowitz U1 , Viuff D2 , Santagostino E3 , Brand B4 , Klamroth R5 , Morfini M6 , Misgav M1 , Tiede A7 , Bjerre J2 1Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel, 2Medical and Science, Haemophilia, Novo Nordisk, Soeborg, Denmark, 3Department of Internal Medicine and Medical Specialties, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital Foundation and University of Milan, Milan, Italy, 4Dept. of Internal Medicine, Division of Haematology, Zurich, Switzerland, 5Vivantes Klinikum im Friedrichshain, Klinik für Innere Medizin – Angiologie und Hämostaseologie, Berlin, Germany, 6Az Osp Careggi Centro Emofilici, Firenze, Italy, 7Hannover Medical School, Dept. Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany 06P47 Comparison of a New Recombinant Factor VIII Product (N8) and Advate ® in an International, Multi-Centre, Randomized and Blinded Field Study of Simulated Post Infusion Samples Viuff D1 , Barrowcliffe T, Ezban M, Saugstrup T, Lillicrap D 1Medical and Science, Haemophilia, Novo Nordisk A/S, 2 3 Soeborg, Denmark, Whitby, U.K., Pharmocology Management, Novo Nordisk A/S, Maalev, Denmark, 4Medical and Science, Haemophilia, Novo Nordisk A/S, Soeborg, Denmark, 5Dep. of Pathology and Molecular Medicine, Richardson Laboratory Queens University, Kingston, ON, Canada 06P48 A Case Presentation of an Unusual Intramural Small Bowel Bleed in a Patient with Severe Hemophilia B Ward J, Craig J, Kerr R Ninewells Hospital & Medical School, Dundee, Angus, U.K. 06P49 Clinical Retrospective Analysis of 780 Patients in a Single Hemophilia Center in China Wu J, Li B, Ding K, Zheng C, Xu X Anhui Provincial Hospital Affiliated of Anhui Medical University, China 06P50 Hemophilic Pseudotumor in Chinese Patients: A Retrospective Single-Center Analysis of 14 Cases Yang R, Xue F, Sun C Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China CLINICAL TRIALS AND POTENTIAL STUDIES 07P08 Continuous Infusion of Clotting Factor Concentrates: More Inhibitor Generation? Auerswald G, Bade A, Moorthi C, Overberg D Prof.-Hess-Children´s Hospital, Bremen, Germany 07P09 The Hemophilia Inhibitor PUP Study (HIPS) – Design and Methods Brown D1 , Reipert B2 , and Santagostino E 3 1University of Texas Health Science Center-Houston and MD Anderson Cancer Center, Houston, Texas, U.S.A., 2Baxter BioScience, Vienna, Austria, 3IRCCS Ca’ Granda Foundation, Policlinico Maggiore Hospital, Milan, Italy 07P10 Reliability of Blinded and Unblinded Acquisition and Interpretation of Ultrasound (US) for Assessment of Hemophilic Knees and Ankles Doria A1 , Keshava S2 , Man C1 , Mohanta A1 , Jarrin J1 , Gibikote S2 1The Hospital for Sick Children, Toronto, ON, Canada, 2Christian Medical College, Vellore, India 07P11 Long-term Clinical Safety of ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method] among Japanese Subjects: A Two-Year Update of the Post- Authorization Safety Surveillance Program Fukutake K1 , Hanabusa H2 , Taki M3 , Shima M4 , Shirahata A5 , Advate PASS study group6 1 2 Tokyo Medical University Hospital, Ogikubo Hospital, Tokyo, 3St. Marianna University School of Medicine Yokohama City Seibu Hospital, Kanagawa, 4Nara Medical University, Nara, 5University of Environmental and Occupational Health Japan, Fukuoka, and 6Baxter BioScience Japan, Medical Affairs Clinical Trial, Tokyo, Japan 49 Posters, Sunday and Monday
Page 1 and 2: Hemophilia Saturday, July 10 - Wedn
Page 3 and 4: Pre-Congress Sessions cont’d 10:3
Page 5 and 6: Pre-Congress Sessions cont’d 15:0
Page 7 and 8: Congress Sessions cont’d S1.6 - M
Page 9 and 10: Congress Sessions cont’d S2.5 - M
Page 11 and 12: Congress Sessions cont’d n Long T
Page 13 and 14: Congress Sessions cont’d M2.4 - M
Page 15 and 16: Congress Sessions cont’d Tuesday,
Page 17 and 18: Congress Sessions cont’d 14:15 -
Page 19 and 20: Congress Sessions cont’d T3.4 - M
Page 21 and 22: Congress Sessions cont’d n Inhibi
Page 23 and 24: Congress Sessions cont’d W2.4 - L
Page 25 and 26: Index of Speakers cont’d Halimeh,
Page 27 and 28: Index of Poster Presenters Sunday a
Page 29 and 30: Index of Poster Presenters cont’d
Page 33: Index of Poster Presenters cont’d

Final Program in it's entirety - MyGirlsBlood

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?